2012
DOI: 10.1097/rli.0b013e31823cc75c
|View full text |Cite
|
Sign up to set email alerts
|

In Vitro and In Vivo High-Intensity Focused Ultrasound Thrombolysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
102
0
2

Year Published

2012
2012
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 104 publications
(109 citation statements)
references
References 51 publications
3
102
0
2
Order By: Relevance
“…In FUS-induced BBB opening, 20,[32][33][34][35][36][37] sonothrombolysis, [38][39][40][41][42] and histotripsy 43,44 studies, correlations between the cavitation activity measured using a single-element passive cavitation detector (PCD) and treatment outcome have been reported. Moreover, microbubble emissions have been used to select treatment pressures 36 and modulate them in real-time between subsequent therapy pulses 35 during FUS-induced BBB opening.…”
Section: Introductionmentioning
confidence: 99%
“…In FUS-induced BBB opening, 20,[32][33][34][35][36][37] sonothrombolysis, [38][39][40][41][42] and histotripsy 43,44 studies, correlations between the cavitation activity measured using a single-element passive cavitation detector (PCD) and treatment outcome have been reported. Moreover, microbubble emissions have been used to select treatment pressures 36 and modulate them in real-time between subsequent therapy pulses 35 during FUS-induced BBB opening.…”
Section: Introductionmentioning
confidence: 99%
“…23,35,67 Inertial acoustic cavitation is the primary mechanism by which MRg-HIFU thrombolysis achieves clot disintegration. 6,11,33,45,57,71,73 Acoustic waves impart momentum to the fluid immediately surrounding the clot, creating microbubbles. 45,73 These microbubbles rapidly collapse along the clot surface, emitting shock waves and liquid jet speeds of more than 1 km/sec, which promote thrombolysis.…”
Section: Technology and Techniquesmentioning
confidence: 99%
“…1,2,9,68 In contrast, MRg-HIFU thrombolysis is an emerging stand-alone therapy for rapid transcranial clot disintegration in patients with ELVO and ICH and, according to in vitro and in vivo models, can potentially achieve recanalization and liquefaction rates of 63%-93% and > 95%, respectively. 10,25,30,45,50,51,73,75 Herein, we review the technological development, preclinical results, and future applications of MRg-HIFU thrombolysis.…”
mentioning
confidence: 99%
“…The first clot was sonicated at 3 points along the clot surface and the second at 3 points along the beam axis for 5 mins at 500W with 0.5% duty cycle. [3] Postsonication, T 1 and T 2 images were taken of the clot samples. The second part of the porcine clot lysis testing involved creating an in-vivo clot in a 5 kg piglet.…”
Section: Porcine Clot Testingmentioning
confidence: 99%